News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

AI-Powered Tech Supercharges Ocean Cleanup, Boosting Plastic Collection by 60%
News Release

BALTIMORE, MD, April 23, 2025 – As plastic pollution in the world’s oceans reaches critical levels, groundbreaking new research reveals how artificial intelligence-driven algorithms can dramatically accelerate plastic waste removal – boosting efficiency by more than 60%.

Read More
China’s rare earth minerals power the modern world. Banning their export could destroy it
Media Coverage

Beijing has a virtual monopoly on rare earth minerals—the materials that power everything from military planes to your electric toothbrush.

Read More
Trump’s tech tariff confusion
Media Coverage
The Trump administration’s back-and-forth moves on tariffs for technology products are stirring confusion in a sector heavily reliant on global supply chains.  
Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Digital Tool Helps Hospital Make Important Coronavirus Retest Decisions

Digital Tool Helps Hospital Make Important Coronavirus Retest Decisions

Georgia Tech News Center, April 13, 2020

What-if questions can torment a doctor making coronavirus retest decisions: What if a patient’s initial negative test was a false negative, and he or she needs a second test? What if they don’t need it, and a retest would use up a scarce test kit and treatments that other patients need?

Fast Coronavirus Test Gets Emergency FDA Approval

Fast Coronavirus Test Gets Emergency FDA Approval

Tech News World, March 31, 2020

Abbott will deliver 50,000 COVID-19 tests per day to healthcare workers, starting Wednesday, using its modified ID NOW testing process, it said. Bringing rapid coronavirus testing capacity to the medical front lines is crucial in the battle to flatten the rising death and infection curve worldwide.

In rare move, Gilead gives up 'orphan' status for experimental coronavirus drug

In rare move, Gilead gives up 'orphan' status for experimental coronavirus drug

Biopharmadive, March 25, 2020

Gilead has asked the Food and Drug Administration to rescind a special regulatory status for its experimental coronavirus drug, but not before stirring up a controversy that had critics accusing the company of manipulating a law designed to spur research into therapies for rare diseases.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine